Carl Bennet, major shareholder and board member of medical technology group Getinge, has increased his stake in the company by 200,000 shares. The total purchase price amounts to approximately SEK 38.5 million, according to the Swedish Financial Supervisory Authority's insider register. The transactions were executed between April 27 and 28.

Prior to the transaction, his holding amounted to 56.2 million shares, representing 20.64 percent of the capital and 50.46 percent of the voting rights, according to the ownership database Holdings.